MorphoSys AG buy FreeWillySW
Summary
This prediction ended on 31.07.09 with a price of €16.32. The BUY prediction by FreeWillySW finished with a performance of 15.91%. FreeWillySW has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 2.219% | 2.219% | 225.695% | -5.356% |
| iShares Core DAX® | 2.831% | 1.236% | 14.788% | 17.647% |
| iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% | 50.762% |
| iShares Nikkei 225® | 2.007% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 2.257% | 0.451% | 30.090% | 43.940% |
Comments by FreeWillySW for this prediction
In the thread Morphosys AG diskutieren
Empfehlung in einem Börsen Magazin
Auf Grund einer Empfehlung in einem Börsen Magazin und das ich diese Aktie in mein KAMA Depot aufgenommen habe werde ich auch hier diese Aktie aufnehmen.